march 19 tirzepatide 10, 2025: Patients transitioning from compounded diabetes / weight loss injections: Stick to licensed sources – Partnership for Safe Medicines Eli Lilly gets nod to
Description
It has not yet been FDA approved, but is showing great promise for weight loss
However, the weight loss and improved metabolic health that semaglutide provides could complement other treatments, particularly for patients who are overweight or obese
The initial trial that used empagliflozin published in 2015, through to the most recent trial that used efpeglenatide published in 2021 were evaluated in detail in the accompanying systematic review and meta-analysis
The thing is, retatrutide is currently in phase 3 clinical trials and is not yet FDA approved
